aclacinomycin has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, PF; Fei, Z; Liao, XL; Lou, B; Wu, MP; Yin, CY | 1 |
| Kanematsu, T; Kusumoto, T; Maehara, Y; Sugimachi, K | 1 |
| Konno, T | 1 |
3 other study(ies) available for aclacinomycin and Cancer of Liver
| Article | Year |
|---|---|
High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Hepatocytes; Humans; Lipoproteins, HDL; Liver Neoplasms | 2005 |
Sensitivity to six antitumor drugs differs between primary and metastatic liver cancers.
Topics: Aclarubicin; Antineoplastic Agents; Carbazilquinone; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Succinate Dehydrogenase | 1988 |
[Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Maleic Anhydrides; Mitomycin; Mitomycins; Naphthacenes; Polystyrenes; Zinostatin | 1987 |